Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 14, 2026
Why Is York Space Systems (YSS) Stock Down 13.03% Today?

Why Is York Space Systems (YSS) Stock Down 13.03% Today?

Key Takeaways

  • -13.03% move: Shares of YSS traded at $10.01 in early Friday trading, down $1.50 from Thursday's close of $11.51.
  • Primary catalyst: York cut full-year 2026 revenue guidance to $375 million–$405 million, down from a prior range of $545 million–$595 million.
  • Secondary drivers: A government shift toward slower-starting IDIQ contracts and supply chain delays are pushing revenue into 2027.
  • Quarterly context: Q2 revenue rose 10% to $92.5 million and gross margin improved, but the outlook cut overwhelmed the results.
  • Analyst reaction: Needham cut its price target to $18 from $33 while maintaining a Buy rating.
  • What traders are watching: IDIQ task-order conversion, supply chain execution, and 2027 demand signals.

Opening Summary

York Space Systems, Inc. (NYSE: YSS) is a Colorado-based space and defense prime that designs, builds, and operates small-satellite platforms and software-enabled mission services for national security, government, and commercial customers. In early trading Friday, the stock fell 13.03% to $10.01, compared with the previous session's closing price of $11.51. The decline followed a second-quarter earnings report in which a sharp reduction to full-year revenue guidance overshadowed stronger-than-expected quarterly revenue and improved gross margin.

Guidance Cut Overwhelms a Solid Q2

York reported second-quarter revenue of $92.5 million, up 10% year over year and modestly above consensus expectations. Gross margin expanded to 24% from 11% a year earlier, while contribution margin improved to 42%. However, the company posted an adjusted loss of $0.31 per share and an adjusted EBITDA loss of $9.5 million, keeping investor attention fixed on the bottom line and the outlook.

The decisive issue was guidance. Management lowered full-year 2026 revenue guidance to a range of $375 million to $405 million, down from a prior range of $545 million to $595 million, a reduction of roughly $180 million at the midpoint. The new forecast implies a significantly slower second half than investors had modeled, and that reset triggered the selloff in YSS shares.

Government Procurement Shift and Supply Chain Delays

York attributed the guidance cut primarily to a structural change in how the U.S. government is buying space capabilities. Instead of a rapid succession of large request-for-proposal awards, agencies are moving toward indefinite-delivery, indefinite-quantity (IDIQ) vehicles that take longer to establish but can accelerate task orders later. Management said roughly 30% of the previous revenue midpoint depended on new business that will no longer convert to recognized revenue in 2026.

Supply chain delays were cited as a roughly equal contributor, pushing some program revenue into 2027. Those impacts are partially offset by contributions from recent acquisitions, including ATLAS Space Operations, Orbion, Solestial, and All.Space. York ended the quarter with backlog of $592 million and an identified pipeline of about $11.5 billion, which management framed as evidence that demand is shifting later rather than disappearing.

Analysts Recalibrate After the Guidance Reset

Wall Street responded by lowering expectations. Needham maintained a Buy rating on YSS but cut its price target to $18 from $33, while Wells Fargo reaffirmed a Buy rating with a $35 target. The adjustments reflect a constructive long-term view on the space franchise paired with a sharp markdown in near-term revenue visibility.

The share-price reaction underscored the disappointment: after closing at $11.51 on Thursday, the stock dropped about 23% in after-hours trading to $8.86 before paring some of those losses into Friday's regular session.

Market Context and Trading Activity

The move was company-specific rather than part of a broad market decline. Major U.S. equity benchmarks were steady to higher Friday morning, while pressure on YSS reflected the guidance reset rather than a sector-wide selloff.

Trading activity was elevated. More than 4.6 million shares changed hands during Thursday's regular session, above the stock's average daily volume of roughly 3.4 million, and selling pressure accelerated in extended trading. In early Friday trading, YSS was testing the lower boundary of its 52-week range around $10.01, leaving the shares far below their January IPO price of $34.

Technically, the $10 area now represents the most closely watched support level, with traders focused on whether buyers defend the bottom of the 52-week range after the post-earnings shock.

What Comes Next for YSS

With full-year guidance now reset, investors will focus on the pace at which IDIQ contract vehicles convert into task orders and recognized revenue. Management said task orders can accelerate once the new vehicles are in place and pointed to 2027 budget priorities as a potential tailwind.

Key signposts include new contract awards and backlog conversion, resolution of supply chain bottlenecks, and the integration of recently closed acquisitions such as All.Space. Additional analyst estimate revisions are likely as the market digests the lower second-half base. Risks include further timing slippage, margin pressure on fixed-price programs, and continued cash burn. The company's next quarterly report is expected later this fall.

Trending AI Robots

Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that are currently performing best under live market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, and only the strongest performers are highlighted in this section. The featured bots vary by strategy, timeframe, performance metrics, and traded symbols. Traders exploring automated strategies can use the page to see which bots are adapting to today's market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: YSS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


YSS in -3.52% downward trend, sliding for three consecutive days on September 03, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where YSS declined for three days, in of 37 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for YSS entered a downward trend on September 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where YSS's RSI Indicator exited the oversold zone, of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for YSS just turned positive on August 14, 2026. Looking at past instances where YSS's MACD turned positive, the stock continued to rise in of 4 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where YSS advanced for three days, in of 22 cases, the price rose further within the following month. The odds of a continued upward trend are .

YSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.703) is normal, around the industry mean (6.482). P/E Ratio (0.000) is within average values for comparable stocks, (56.451). YSS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.916). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (2.851) is also within normal values, averaging (19.342).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. YSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 41.58B. The market cap for tickers in the group ranges from 4.49 to 2.02T. SPCX holds the highest valuation in this group at 2.02T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 11%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -8%. MRLN experienced the highest price growth at 21%, while KITT experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 40%. For the same stocks of the Industry, the average monthly volume growth was -28% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 69
Price Growth Rating: 65
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
YSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
6060 S. Willow Drive
Phone
+1 720 537-2655
Employees
710
Web
https://www.yorkspacesystems.com
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.